1988
DOI: 10.1097/00000542-198801000-00025
|View full text |Cite
|
Sign up to set email alerts
|

The Treatment of Reflex Sympathetic Dystrophy with Intravenous Regional Bretylium

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
8
0
1

Year Published

1991
1991
2004
2004

Publication Types

Select...
5
5

Relationship

0
10

Authors

Journals

citations
Cited by 35 publications
(9 citation statements)
references
References 0 publications
0
8
0
1
Order By: Relevance
“…The tourniquet is inflated, and bretylium (1.25 mg/kg lean body weight) is administered intravenously, to decrease the risk of postoperative pain syndromes. [73][74][75] The previous incision is usually extended, the soft tissue is dissected, and the branches of the medial antebrachial cutaneous nerve are identified. If a neuroma is observed on the medial antebrachial cutaneous nerve, then it is excised and the nerve branch is cauterized and transposed into the muscle of the upper arm.…”
Section: Preferred Surgical Treatment For Secondary Cubital Tunnel Symentioning
confidence: 99%
“…The tourniquet is inflated, and bretylium (1.25 mg/kg lean body weight) is administered intravenously, to decrease the risk of postoperative pain syndromes. [73][74][75] The previous incision is usually extended, the soft tissue is dissected, and the branches of the medial antebrachial cutaneous nerve are identified. If a neuroma is observed on the medial antebrachial cutaneous nerve, then it is excised and the nerve branch is cauterized and transposed into the muscle of the upper arm.…”
Section: Preferred Surgical Treatment For Secondary Cubital Tunnel Symentioning
confidence: 99%
“…They are performed by the intravenous injection of a variety of therapeutic medications after the tourniquet is placed to minimize further spread of the agent. Bretylium [53], ketanserin [54], and ketorolac [55] demonstrated some efficacy in pain inhibition when given regionally.…”
Section: Table 2 Proposed Modified Research Diagnostic Criteria For mentioning
confidence: 99%
“…Intravenous regional bretylium has also been used because of its ability to accumulate in adrenergic nerves and block NE release [91]. In addition, bretylium produced objective signs of prolonged sympatholytic activity and improved function in all four patients, and side effects were minimal.…”
Section: Intravenous Regional Blockmentioning
confidence: 99%